Rizzardo S - Search Results

1

Expensive Drugs for Rare Diseases in Canada: What Value and at What Cost?

Sirrs S, Anderson H, Jiwani B, Lynd LD, Lun E, Nakagawa B, Regier D, Rizzardo S, McFarlane A. Sirrs S, et al. Among authors: rizzardo s. Healthc Pap. 2023 Jan;21(1):10-26. doi: 10.12927/hcpap.2023.27000. Healthc Pap. 2023. PMID: 36692912 Free article. Review.

2

Challenges in measuring the societal value of orphan drugs: insights from a canadian stated preference survey.

Dragojlovic N, Rizzardo S, Bansback N, Mitton C, Marra CA, Lynd LD. Dragojlovic N, et al. Among authors: rizzardo s. Patient. 2015 Feb;8(1):93-101. doi: 10.1007/s40271-014-0109-5. Patient. 2015. PMID: 25586645

3

Evaluating Canadians' Values for Drug Coverage Decision Making.

Rizzardo S, Bansback N, Dragojlovic N, Douglas C, Li KH, Mitton C, Marra C, Blanis L, Lynd LD. Rizzardo S, et al. Value Health. 2019 Mar;22(3):362-369. doi: 10.1016/j.jval.2018.08.008. Epub 2018 Nov 27. Value Health. 2019. PMID: 30832975 Free article.

4

Expensive Drugs for Rare Diseases in Canada: Time for Action Everywhere and by Everyone.

Sirrs S, Anderson H, Jiwani B, Lun E, Nakagawa B, Regier D, Rizzardo S, McFarlane A. Sirrs S, et al. Among authors: rizzardo s. Healthc Pap. 2023 Jan;21(1):74-80. doi: 10.12927/hcpap.2023.26992. Healthc Pap. 2023. PMID: 36692920 Free article.

5

Is Canada missing out? An assessment of drugs approved internationally between 2016 and 2020 and not submitted for Health Canada review.

Gaudette É, Rizzardo S, Wladyka SB, Rahman T, Pothier KR. Gaudette É, et al. Among authors: rizzardo s. CMAJ. 2023 Jun 12;195(23):E815-E820. doi: 10.1503/cmaj.230339. CMAJ. 2023. PMID: 37308215 Free PMC article. No abstract available.

6

Cost-effectiveness of the top 100 drugs by public spending in Canada, 2015-2021: a repeated cross-sectional study.

Gaudette É, Rizzardo S, Zhang Y, Pothier KR, Tadrous M. Gaudette É, et al. Among authors: rizzardo s. BMJ Open. 2024 Mar 13;14(3):e082568. doi: 10.1136/bmjopen-2023-082568. BMJ Open. 2024. PMID: 38485176 Free PMC article.

7

Le Canada manque-t-il le bateau? Un inventaire des médicaments approuvés à l’international entre 2016 et 2020 qui n’ont pas été soumis à Santé Canada.

Gaudette É, Rizzardo S, Wladyka SB, Rahman T, Pothier KR. Gaudette É, et al. Among authors: rizzardo s. CMAJ. 2023 Sep 5;195(34):E1161-E1167. doi: 10.1503/cmaj.230339-f. CMAJ. 2023. PMID: 37669791 Free PMC article. French. No abstract available.

8

Letter to the Editor: Dolutegravir Monotherapy and Body Weight Gain in Antiretroviral Naïve Patients.

Lanzafame M, Rizzardo S, Lattuada E, Luise D, Vento S. Lanzafame M, et al. Among authors: rizzardo s. AIDS Res Hum Retroviruses. 2022 Oct;38(10):771-773. doi: 10.1089/AID.2021.0234. Epub 2022 Aug 3. AIDS Res Hum Retroviruses. 2022. PMID: 35815473 No abstract available.

9

"Long COVID" results after hospitalization for SARS-CoV-2 infection.

Rigoni M, Torri E, Nollo G, Donne LD, Rizzardo S, Lenzi L, Falzone A, Cozzio S. Rigoni M, et al. Among authors: rizzardo s. Sci Rep. 2022 Jun 10;12(1):9581. doi: 10.1038/s41598-022-13077-5. Sci Rep. 2022. PMID: 35688830 Free PMC article.

10

Development and pilot evaluation of an educational session to support sparing opioid prescriptions to opioid naïve patients in a Canadian primary care setting.

Narayan S, Rizzardo S, Hamilton MA, Cooper I, Maclure M, McCracken RK, Klimas J. Narayan S, et al. Among authors: rizzardo s. Fam Pract. 2022 Nov 22;39(6):1024-1030. doi: 10.1093/fampra/cmac044. Fam Pract. 2022. PMID: 35543305 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page